Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
168.40    -2.00 (-1.17%)
Bid:
169.00
Ask:
170.00
Spread: 1.00 (0.592%)
Market Cap: £206.65m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

Director Declaration

19 Jun 2025 14:30

RNS Number : 6276N
SThree plc
19 June 2025
 

19 June 2025

 

 

SThree plc

 

(the "Company")

 

Appointment of Senior Independent Director and changes in Directors' Responsibilities

 

As previously announced on 24 January 2025, having served as a non-executive director for nineyears, Denise Collis will be retiring from the Board on 30 June 2025.

In accordance with UKLR 6.4.6, SThree plc, the global STEM workforce consultancy, todayannounces that, with effect from 1 July 2025, Imogen Joss, who was appointed to the Board in December 2022, will become Senior Independent Director and Chair of the Remuneration Committee and Sanjeevan Bala, who was appointed to the Board in April 2024, will become Employee Engagement NED.

James Bilefield, Chair, said:

"I am immensely grateful to Denise for her significant contribution and dedication since her appointment. In addition to successfully discharging her responsibilities as our Senior Independent Director and Remuneration Committee Chair, Denise fully embraced the role of being our first Employee Engagement NED and has been a champion of and mentor to many of our colleagues in the business. I look forward to working with Imogen and Sanjeevan in their new roles."

 

 

Enquiries:

 

 

 

SThree plc

Timo Lehne, CEO

Andrew Beach, CFO

Keren Oser, Investor Relations Director

 

 

 via Alma

Alma Strategic Communications

+44 20 3405 0205

 

Rebecca Sanders-Hewett

Hilary Buchanan

Sam Modlin

Will Ellis Hancock

SThree@almastrategic.com

 

 

 

Notes to editors

SThree plc brings skilled people together to build the future. We are the global STEM workforce consultancy, placing highly skilled, STEM specialist workers in the industries where they are needed most. We advise businesses, build expert teams, and deliver project solutions for our clients. With more than 38 years of experience in pure-play STEM and a global team with local expertise across 11 countries, we cover high-demand skills across Engineering, Life Sciences and Technology roles.

 

We provide permanent and flexible contract talent to a diverse base of around 6,000 clients. By combining advanced technology with expertise, we push beyond traditional boundaries to deliver tailored solutions, leveraging data and insight from our world-class operating platform.

 

Outpace tomorrow, together

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNFLMJTMTMBBRA
Date   Source Headline
2nd Sep 20242:30 pmRNSChange of Registered Office
2nd Sep 202410:51 amRNSTotal Voting Rights
23rd Aug 202411:00 amRNSBlock listing Interim Review
12th Aug 20242:00 pmRNSDirector/PDMR Shareholding
1st Aug 202411:30 amRNSTotal Voting Rights
23rd Jul 20245:31 pmRNSDirector/PDMR Shareholding
23rd Jul 20247:01 amRNSNotice of Investor Briefing
23rd Jul 20247:00 amRNSFY24 Half Year Results
16th Jul 20247:00 amRNSNotice of Third Investor Briefing
12th Jul 20243:30 pmRNSDirector/PDMR Shareholding
1st Jul 202411:42 amRNSTotal Voting Rights
18th Jun 20247:00 amRNSFY24 Half Year Trading Update
13th Jun 20241:26 pmRNSDirector/PDMR Shareholding
11th Jun 20242:35 pmRNSDirector/PDMR Shareholding
3rd Jun 20249:50 amRNSTotal Voting Rights
13th May 20244:00 pmRNSDirector/PDMR Shareholding
25th Apr 202411:44 amRNSResult of AGM
15th Apr 20243:48 pmRNSDirector/PDMR Shareholding
10th Apr 202412:14 pmRNSChange of Auditor
2nd Apr 202412:10 pmRNSDirectorate Change
22nd Mar 20244:29 pmRNSDirector/PDMR Shareholding
19th Mar 20243:30 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFY24 Q1 Trading Update
14th Mar 202412:11 pmRNSDirector/PDMR Shareholding
12th Mar 20243:59 pmRNSDirector/PDMR Shareholding
7th Mar 20249:20 amRNSDirector/PDMR Shareholding
4th Mar 202410:54 amRNSAnnual Financial Report
23rd Feb 20242:00 pmRNSBlock listing Interim Review
13th Feb 20244:45 pmRNSDirector/PDMR Shareholding
1st Feb 202410:20 amRNSTotal Voting Rights
30th Jan 20247:00 amRNSFY23 Final Results
23rd Jan 20244:25 pmRNSChange of Registrar
15th Jan 20241:19 pmRNSDirector/PDMR Shareholding
18th Dec 20234:56 pmRNSDirector/PDMR Shareholding
14th Dec 202310:58 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSFY23 Full Year Trading Update
8th Dec 20234:30 pmRNSDirectorate Change
1st Dec 20232:27 pmRNSTotal Voting Rights
23rd Nov 20237:00 amRNSAppointment of Joint Corporate Brokers
16th Nov 202312:41 pmRNSDirector/PDMR Shareholding
14th Nov 20239:45 amRNSHolding(s) in Company
2nd Nov 20232:45 pmRNSTotal Voting Rights
16th Oct 20232:02 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:53 pmRNSTotal Voting Rights
20th Sep 20231:19 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFY23 Q3 Trading Update
13th Sep 202310:35 amRNSDirector/PDMR Shareholding
1st Sep 202312:17 pmRNSTotal Voting Rights
23rd Aug 202311:40 amRNSBlock listing Interim Review
16th Aug 20232:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.